125 related articles for article (PubMed ID: 14508106)
1. A novel function for the rTS gene.
Dolnick BJ; Angelino NJ; Dolnick R; Sufrin JR
Cancer Biol Ther; 2003; 2(4):364-9. PubMed ID: 14508106
[TBL] [Abstract][Full Text] [Related]
2. Alternate splicing of the rTS gene product and its overexpression in a 5-fluorouracil-resistant cell line.
Dolnick BJ; Black AR
Cancer Res; 1996 Jul; 56(14):3207-10. PubMed ID: 8764108
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of 5-fluorouracil sensitivity by an rTS signaling mimic in H630 colon cancer cells.
Dolnick R; Wu Q; Angelino NJ; Stephanie LV; Chow KC; Sufrin JR; Dolnick BJ
Cancer Res; 2005 Jul; 65(13):5917-24. PubMed ID: 15994970
[TBL] [Abstract][Full Text] [Related]
4. Natural antisense (rTSalpha) RNA induces site-specific cleavage of thymidylate synthase mRNA.
Chu J; Dolnick BJ
Biochim Biophys Acta; 2002 Jul; 1587(2-3):183-93. PubMed ID: 12084460
[TBL] [Abstract][Full Text] [Related]
5. A novel methionine-based signaling mechanism regulating the expression of thymidylate synthase.
Chu E
Cancer Biol Ther; 2003; 2(4):370-1. PubMed ID: 14508107
[No Abstract] [Full Text] [Related]
6. Comparative genomic analysis reveals a novel mitochondrial isoform of human rTS protein and unusual phylogenetic distribution of the rTS gene.
Liang P; Nair JR; Song L; McGuire JJ; Dolnick BJ
BMC Genomics; 2005 Sep; 6():125. PubMed ID: 16162288
[TBL] [Abstract][Full Text] [Related]
7. rTS gene expression is associated with altered cell sensitivity to thymidylate synthase inhibitors.
Dolnick BJ; Black AR; Winkler PM; Schindler K; Hsueh CT
Adv Enzyme Regul; 1996; 36():165-80. PubMed ID: 8869746
[TBL] [Abstract][Full Text] [Related]
8. The rTS signaling pathway as a target for drug development.
Dolnick BJ
Clin Colorectal Cancer; 2005 May; 5(1):57-60. PubMed ID: 15929807
[TBL] [Abstract][Full Text] [Related]
9. The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger.
Berg RW; Ferguso PJ; DeMoor JM; Vincen MD; Koropatnick J
Curr Drug Targets; 2002 Aug; 3(4):297-309. PubMed ID: 12102601
[TBL] [Abstract][Full Text] [Related]
10. Expression of rTSbeta as a 5-fluorouracil resistance marker in patients with primary breast cancer.
Kuo SJ; Wang HC; Chow KC; Chiou SH; Chiang SF; Lin TY; Chiang IP; Chen DR
Oncol Rep; 2008 Apr; 19(4):881-8. PubMed ID: 18357371
[TBL] [Abstract][Full Text] [Related]
11. rTSbeta as a novel 5-fluorouracil resistance marker of colorectal cancer: a preliminary study.
Lin YL; Chow KC
Ann Acad Med Singap; 2010 Feb; 39(2):107-11. PubMed ID: 20237731
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of a naturally occurring antisense RNA to human thymidylate synthase mRNA.
Dolnick BJ
Nucleic Acids Res; 1993 Apr; 21(8):1747-52. PubMed ID: 8493092
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA.
Lin X; Parsels LA; Voeller DM; Allegra CJ; Maley GF; Maley F; Chu E
Nucleic Acids Res; 2000 Mar; 28(6):1381-9. PubMed ID: 10684933
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
[TBL] [Abstract][Full Text] [Related]
15. Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription.
DeMoor JM; Vincent MD; Collins OM; Koropatnick J
Exp Cell Res; 1998 Aug; 243(1):11-21. PubMed ID: 9716444
[TBL] [Abstract][Full Text] [Related]
16. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
Chu E; Koeller DM; Johnston PG; Zinn S; Allegra CJ
Mol Pharmacol; 1993 Apr; 43(4):527-33. PubMed ID: 8474431
[TBL] [Abstract][Full Text] [Related]
17. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
[TBL] [Abstract][Full Text] [Related]
18. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
Ichikawa W; Uetake H; Shirota Y; Yamada H; Nishi N; Nihei Z; Sugihara K; Hirayama R
Clin Cancer Res; 2003 Feb; 9(2):786-91. PubMed ID: 12576451
[TBL] [Abstract][Full Text] [Related]
19. Antisense thymidylate synthase electrogene transfer to increase uptake of radiolabeled iododeoxyuridine in a murine model.
Chi KH; Wang HE; Wang YS; Chou SL; Yu HM; Tseng YH; Hwang IM; Lui WY
J Nucl Med; 2004 Mar; 45(3):478-84. PubMed ID: 15001691
[TBL] [Abstract][Full Text] [Related]
20. A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance.
Berg RW; Ferguson PJ; Vincent MD; Koropatnick DJ
Cancer Gene Ther; 2003 Apr; 10(4):278-86. PubMed ID: 12679800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
